These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 226704)

  • 1. Photoaffinity labeling of the angiotensin II receptor. 3. Receptor inactivation with photolabile hormone analogues.
    Escher EH; Guillemette G
    J Med Chem; 1979 Sep; 22(9):1047-50. PubMed ID: 226704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoaffinity labeling of the angiotensin II receptor. 1. Synthesis and biological activities of the labeling peptides.
    Escher EH; Nguyen TM; Robert H; St-Pierre SA; Regoli DC
    J Med Chem; 1978 Sep; 21(9):860-4. PubMed ID: 214562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photochemical inactivation of the angiotensin receptor of rabbit aorta by N alpha-(2-nitro-5-azidobenzoyl)-[1-aspartic acid,5-isoleucine]angiotensin II.
    Galardy RE; LaVorgna KA
    J Med Chem; 1981 Apr; 24(4):362-6. PubMed ID: 6267278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoaffinity labeling of the angiotensin II receptor; pharmacology of the labeling peptides in the dark.
    Escher E; Nguyen TM; Regoli D
    Can J Physiol Pharmacol; 1978 Dec; 56(6):956-62. PubMed ID: 217511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the adrenal angiotensin II receptor with the photoaffinity labeling method.
    Guillemette G; Escher E
    Biochemistry; 1983 Nov; 22(24):5591-6. PubMed ID: 6317023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activities of photoaffinity labeling analogues of kinins and their irreversible effects on kinin receptors.
    Escher E; Laczkó E; Guillemette G; Regoli D
    J Med Chem; 1981 Dec; 24(12):1409-13. PubMed ID: 6118437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that [Sar1]angiotensin II behaves differently from angiotensin II at angiotensin AT1 receptors in rabbit aorta.
    Liu YJ
    Eur J Pharmacol; 1993 Apr; 235(1):9-15. PubMed ID: 8519284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological properties of two analogues of angiotensin II containing carboranylalanine (Car).
    Escher E; Guillemette G; Leukart O; Regoli D
    Eur J Pharmacol; 1980 Sep; 66(4):267-72. PubMed ID: 7418720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific and irreversible block of the myotropic action of angiotensin II.
    Escher EH; Nguyen TM; Guillemette G; Regoli DC
    Nature; 1978 Sep; 275(5676):145-6. PubMed ID: 211425
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of D-amino acid substitution on antagonist activities of angiotensin II analogues.
    Samanen J; Narindray D; Adams W; Cash T; Yellin T; Regoli D
    J Med Chem; 1988 Mar; 31(3):510-6. PubMed ID: 3346871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topographic probes of angiotensin and receptor: potent angiotensin II agonist containing diphenylalanine and long-acting antagonists containing biphenylalanine and 2-indan amino acid in position 8.
    Hsieh KH; LaHann TR; Speth RC
    J Med Chem; 1989 Apr; 32(4):898-903. PubMed ID: 2704034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel cyclic analogs of angiotensin II with cyclization between positions 5 and 7: conformational and biological implications.
    Zhang WJ; Nikiforovich GV; Pérodin J; Richard DE; Escher E; Marshall GR
    J Med Chem; 1996 Jul; 39(14):2738-44. PubMed ID: 8709104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarmesin is a partial agonist of angiotensin-II receptors in rabbit, but not in rat, aortic rings.
    Criscione L; Thomann H; Whitebread S; de Gasparo M; Kamber B
    Biochem Biophys Res Commun; 1990 Jun; 169(2):636-42. PubMed ID: 2357223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational restriction of angiotensin II: cyclic analogues having high potency.
    Spear KL; Brown MS; Reinhard EJ; McMahon EG; Olins GM; Palomo MA; Patton DR
    J Med Chem; 1990 Jul; 33(7):1935-40. PubMed ID: 2362273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the influence of tyrosine deprotonation on the myotropic action of angiotensin II.
    Escher E; Guillemette G
    Can J Physiol Pharmacol; 1979 Mar; 57(3):317-20. PubMed ID: 36212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activities of photoaffinity labeling analogues of substance P.
    Escher E; Couture R; Champagne G; Mizrahi J; Regoli D
    J Med Chem; 1982 Apr; 25(4):470-5. PubMed ID: 6175752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships for the carboxy-terminus truncated analogues of angiotension II, a new class of angiotensin II antagonists.
    Bovy PR; O'Neal JM; Olins GM; Patton DR; McMahon EG; Palomo M; Koepke JP; Salles KS; Trapani AJ; Smits GJ
    J Med Chem; 1990 May; 33(5):1477-82. PubMed ID: 2329570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activities of angiotensin II, Sarilesin, and Sarmesin analogues containing Aze or Pip at position 7.
    Matsoukas JM; Agelis G; Hondrelis J; Yamdagni R; Wu Q; Ganter R; Smith JR; Moore D; Moore GJ
    J Med Chem; 1993 Apr; 36(7):904-11. PubMed ID: 8464045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor binding interactions of the angiotensin II antagonist, 125I-[sarcosine1,leucine8]angiotensin II, with mammalian brain and peripheral tissues.
    Bennett JP; Snyder SH
    Eur J Pharmacol; 1980 Oct; 67(1):11-25. PubMed ID: 6252019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologically active derivatives of angiotensin for labeling cellular receptors.
    Galardy RE; Stafford SS; Schaefer ML; Ho H; La Vorgna KA; Jamieson JD
    J Med Chem; 1978 Dec; 21(12):1279-83. PubMed ID: 214560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.